Success in getting prescription and OTC drugs on the market depends a lot on how well they work in a clinical trial. And as we see more and more CROs pop up all over the world, more clinical trial opportunities have arisen, and that is good. But as the University of Oxford's Trudie Lang and Sisira Siribaddana report in their study titled "Clinical Trials Have Gone Global: Is This a Good Thing?" government regulations for clinical trials in developing nations can put a damper in how they are organized and administered. An abstract of the study is available to read on PLoS Medicine.